People with Parkinson’s urgently need new treatments. But right now, there’s a huge gap in drug development.
There’s no shortage of exciting research discoveries happening. And pharmaceutical companies are ready to fund large-scale trials and get new drugs to market. But the middle stage, taking promising research and developing it into plausible drug treatments? That’s where we see a critical funding shortage.
At Parkinson’s UK, we’re stepping up to fund that gap.
And we’re not doing it alone. We’re a powerful global movement of scientists and supporters, investors and innovators. Driven by people with Parkinson’s every step of the way. We are aiming to invest at least a further £20million in our Virtual Biotech to deliver a life-changing new treatment to people with Parkinson’s by the end of 2024.
About the Parkinson's Virtual Biotech
A biotech is a company using biological research to make treatments. Our Virtual Biotech is a little different. Unlike a traditional biotech, none of our funding is tied up in bricks or people. We have no large teams of scientists or expensive labs to run.
We take an agile approach. Partnering with institutions and pharmaceutical companies worldwide that already have the expertise, tools and infrastructure. Fast tracking the projects with the greatest potential to transform life for people with Parkinson’s.
We monitor and manage each project. If one stalls, we redirect the funding into one that’s more promising. With none of the usual limitations, we can fund multiple biotech projects at once.
Any profit we make? That goes straight into the next project.
Right now, we have projects at the discovery, preclinical and early clinical development stages. With guidance from our panel of industry and scientific experts, we are selecting projects with the greatest potential.
No one else is doing this. We’re taking bold risks. And we believe we’ll deliver a groundbreaking new treatment by the end of 2024.
Because people with Parkinson’s won’t wait.
We believe that together, we’ll find a cure.
Work with us
We partner with organisations from around the globe to accelerate progress towards new and better treatments. Our flexible approach and in-house expertise make us the ideal partner.
Discover more about what we look for in a project by visiting the Parkinson's Virtual Biotech website.
Together, we'll find a cure
Since the charity was founded in 1969, we've invested over £100 million into research that has led to new therapies, better diagnosis and countless breakthroughs. But we still need to do more.
Discover our history and our future as we invest in initiatives that accelerate research. And find out about your role in driving forward groundbreaking new treatments.